Multiple myeloma trials in United States

In United States 297 Also abroad 703

297 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Long-term Follow-up Study of Patients Receiving CAR-T Cells
Where
Milwaukee
Age
18 years to 80 years
People
500
Run by
Medical College of Wisconsin
See details and how to joinNCT03375619
No phaseTaking people
Sleep Apnea in Patients With MGUS and MM
Where
Iowa City
Age
18 years to 99 years
People
200
Run by
Michael Tomasson
See details and how to joinNCT04114084
No phaseTaking people
Activity Levels in Bone Marrow Transplant Patients
Where
Iowa City
Age
18 years to 99 years
People
200
Run by
Michael Tomasson
See details and how to joinNCT04115241
Phase 2Taking people
Two Step Haplo With Radiation Conditioning
Where
Philadephia
Age
18 years and over
People
63
Run by
Thomas Jefferson University
See details and how to joinNCT05031897
No phaseTaking people
Umbilical Cord Blood Transplantation From Unrelated Donors
Where
Rochester
Age
2 months to 75 years
People
30
Run by
University of Rochester
See details and how to joinNCT03016806
Phase 1Taking people
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Where
Aurora, Birmingham, Charlotte, Cincinnati, Cleveland, Dallas, Durham, Hackensack, Lexington, Miami, Milwaukee, Nashville, New York, Richmond, Salt Lake City
Age
18 years and over
People
50
Run by
Caribou Biosciences, Inc.
See details and how to joinNCT05722418
Phase 1/2Taking people
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Where
Baltimore, Birmingham, Boston, Hackensack, New York
Age
18 years and over
People
260 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT05372354 · EU 2023-509384-25-00
No phaseTaking people
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
Where
Detroit
Age
18 years and over
People
120
Run by
Barbara Ann Karmanos Cancer Institute
See details and how to joinNCT06908629
Phase 1/2Taking people
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Where
Atlanta, Cleveland, Fairfax, Houston, Lake Mary, Los Angeles, Minneapolis, Nashville, New York, Portland, Providence, Winston-Salem
Age
18 years and over
People
128
Run by
Indapta Therapeutics, INC.
See details and how to joinNCT06119685
No phaseTaking people
PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
Where
Seattle
Age
18 years and over
People
100
Run by
Pack Health
See details and how to joinNCT05956457
Early phase 1Taking people
VitD3 Supplementation in Patients With Multiple Myeloma
Where
Augusta
Age
18 years and over
People
100
Run by
Amany Keruakous, MD, MS.
See details and how to joinNCT05846880
Phase 2Taking people
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
Where
Rochester
Age
18 years and over
People
15
Run by
University of Rochester
See details and how to joinNCT05597345
Phase 2Taking people
A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
Where
Omaha, West Hollywood
People
39
Run by
Oncotherapeutics
See details and how to joinNCT06115135
Phase 1Taking people
A Trial of Selinexor, Ruxolitinib and Methylprednisolone
Where
West Hollywood
People
30
Run by
Oncotherapeutics
See details and how to joinNCT06225310
Early phase 1Taking people
Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma
Where
West Hollywood
Age
18 years and over
People
30
Run by
Oncotherapeutics
See details and how to joinNCT06209606
No phaseTaking people
Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab
Where
Houston, Seattle
Age
18 years and over
People
50
Run by
Pack Health
See details and how to joinNCT05053607
Phase 3Taking people
Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan
Where
Augusta
Age
18 years and over
People
172
Run by
Augusta University
See details and how to joinNCT06588413
Phase 1Taking people
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
Where
Atlanta
Age
18 years to 75 years
People
81
Run by
OriCell Therapeutics Co., Ltd.
See details and how to joinNCT06271252
No phaseEnrolling by invitation
ASH Research Collaborative Data Hub
Where
Washington D.C.
People
100,000
Run by
ASH Research Collaborative
See details and how to joinNCT05775224
No phaseTaking people
Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma
Where
Seattle
Age
18 years and over
People
450
Run by
All4Cure
See details and how to joinNCT06149910
Phase 1Taking people
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Where
Alhambra, Bakersfield, Bethesda, Encinitas, Fountain Valley, Jacksonville, Monterey, Pembroke Pines, Santa Barbara, Tacoma, West Hills, West Hollywood
Age
18 years and over
People
134
Run by
Oncotherapeutics
See details and how to joinNCT03110822
No phaseTaking people
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
Where
Minneapolis
People
544
Run by
Center for International Blood and Marrow Transplant Research
See details and how to joinNCT03127761